RTP startup targeting stroke treatment raises $1.9M, wants another $5M
Life science startup Basking Biosciences, which is developing what it believes will be a reversible anti-thrombotic therapeutic to treat ischemic stroke, has closed on $1.9 million in financing and is seeking more.
Read More
